相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo
Gautam Sethi et al.
MOLECULAR CANCER (2014)
Drug repositioning by structure-based virtual screening
Dik-Lung Ma et al.
CHEMICAL SOCIETY REVIEWS (2013)
In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity
Malgorzata Szelag et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
STAT inhibitors for cancer therapy
Muhammad Furqan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Therapeutic modulators of STAT signalling for human diseases
Gabriella Miklossy et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Muhammad Furqan et al.
BIOMARKER RESEARCH (2013)
Discovery of a natural product inhibitor targeting protein neddylation by structure-based virtual screening
Hai-Jing Zhong et al.
BIOCHIMIE (2012)
Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth
Shui Ping Tu et al.
CANCER PREVENTION RESEARCH (2012)
Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice
Grace-Ifeyinwa Onimoe et al.
INVESTIGATIONAL NEW DRUGS (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
Sangkil Nam et al.
MOLECULAR ONCOLOGY (2012)
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
Xiaolei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chemosensitization of tumors by resveratrol
Subash C. Gupta et al.
RESVERATROL AND HEALTH (2011)
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
Stacey L. Fossey et al.
BMC CANCER (2011)
A natural product-like inhibitor of NEDD8-activating enzyme
Chung-Hang Leung et al.
CHEMICAL COMMUNICATIONS (2011)
Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor
Ken Miyoshi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
STAT3 SIGNALING: Anticancer Strategies and Challenges
Paul A. Johnston et al.
MOLECULAR INTERVENTIONS (2011)
Structure-Based Discovery of Natural-Product-like TNF-alpha Inhibitors
Daniel Shiu-Hin Chan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes
Xiaolei Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression
W. Glienke et al.
CANCER INVESTIGATION (2010)
Identification of natural product Fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening
Ho-Man Lee et al.
CHEMICAL COMMUNICATIONS (2010)
Evaluation of anti-leukemia effect of resveratrol by modulating SATA3 signaling
Tan Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
KIDNEY INTERNATIONAL (2010)
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Jinbo Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?
Bharat B. Aggarwal et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Synthesis, discovery and preliminary SAR study of benzofuran derivatives as angiogenesis inhibitors
Yuan Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
Dae-Seop Shin et al.
CANCER RESEARCH (2009)
STAT3 in CD4+ T helper cell differentiation and inflammatory diseases
Charles E. Egwuagu
CYTOKINE (2009)
Targeting STAT3 in cancer: how successful are we?
Pedbin Yue et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Resveratrol addiction: To die or not to die
Mehdi Shakibaei et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression
Ja Eun Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2008)
Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
Gabriella Regis et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Paradigm shifts in the cell biology of STAT signaling
Pravin B. Sehgal
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
SOCS regulation of the JAK/STAT signalling pathway
Ben A. Croker et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects
Khandaker A. Z. Siddiquee et al.
ACS CHEMICAL BIOLOGY (2007)
STAT3 as a central mediator of neoplastic cellular transformation
David A. Frank
CANCER LETTERS (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The JAK-STAT signaling pathway: Input and output intergration
Peter J. Murray
JOURNAL OF IMMUNOLOGY (2007)
Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor
JV Alvarez et al.
CANCER RESEARCH (2006)
STAT3 as a therapeutic target in head and neck cancer
RJ Leeman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Regulation of cytokine signaling pathways by PIAS proteins
K Shuai
CELL RESEARCH (2006)
Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer
NJ Jing et al.
MOLECULAR CANCER THERAPEUTICS (2006)
STAT3 in immune responses and inflammatory bowel diseases
XY Fu
CELL RESEARCH (2006)
A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells
J Turkson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synthesis and evaluation of 3-methyl-4-oxo-6-phenyl-4,5,6,7-tetrahydrobenzofuran-2-carboxylic acid ethyl ester derivatives as potent antitumor agents
I Hayakawa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2005)
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
H Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach:: implications for cancer therapy
SC Xi et al.
ONCOGENE (2005)
Inhibitors of cytokine signal transduction
S Wormald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis
CM Silva
ONCOGENE (2004)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours
R Lai et al.
JOURNAL OF PATHOLOGY (2003)
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation
J Turkson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
